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Abstract
The Wnt/b-catenin signalling pathway shares a key component, b-catenin, with the cadherin-based adhesion system. The
signalling function of b-catenin is conferred by a soluble cytoplasmic pool that is unstable in the absence of a Wnt signal, whilst
the adhesion function is based on a cadherin-bound, stable pool at themembrane. The cadherin complex is dynamic, allowing for
cell-cell rearrangements such as epithelial-mesenchymal transition (EMT), where the complex turns over through internalisation.
Potential interplay between the two pools remains poorly understood, but cadherins are generally considered negative regulators
of Wnt signalling because they sequester cytoplasmic b-catenin. Here we explore how cellular changes at EMT affect the signalling
capacity of b-catenin using two models of EMT: hepatocyte growth factor (HGF) treatment of MDCK cells, and gastrulation in
embryonic development. We show that EMT not only provides a pool of signalling-competent b-catenin following internalisation
of cadherin, but also significantly facilitates activation of the Wnt pathway in response to both Wnt signals and exogenous b-
catenin. We further demonstrate that availability of b-catenin in the cytoplasm does not necessarily correlate with Wnt/b-catenin
pathway activity, since blocking endocytosis or depleting endogenous cadherin abolishes pathway activation despite the
presence of b-catenin in the cytoplasm. Lastly we present data suggesting that cadherins are required for augmented activation of
the Wnt/b-catenin pathway in vivo. This suggests that cadherins play a crucial role in b-catenin-dependent transcription.
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Introduction
During embryogenesis and in adulthood, cells undergo dynamic
morphological rearrangements, including changes in cell-cell
adhesion, which are essential for driving both morphogenetic
processes, such as gastrulation, and differentiation into distinct
tissues. These cellular changes critically depend upon precise
interactions between neighbouring cells and tight regulation of
gene expression; dysregulation of either may lead to perturbed cell
proliferation, adhesion, migration or differentiation, all of which
are hallmarks of diseases such as cancer.
The cadherin/catenin-based adhesion system is the major
means by which cells adhere to one another. b-catenin, a central
structural component of this adhesion complex, also acts as a
transcriptional co-activator in the Wnt signalling pathway, a
pathway used reiteratively during development to control cell fate
decisions and one implicated in cancer in many tissues. The
current, and somewhat uncontested, understanding of this
pathway is that Wnt receptor activation inhibits the degradation
of newly synthesised b-catenin, allowing for a de novo synthesised,
cadherin-free form of b-catenin to enter the nucleus and, together
with LEF/TCF, activate Wnt target genes [1]. In fact, it has been
shown that Wnt signalling generates a form of b-catenin that binds
TCF but not cadherin, suggesting that b-catenin used for
transcription is molecularly distinct from that used for adhesion
[2]. Despite this finding, there has been much speculation over
whether the cadherin-bound and signal transduction pools of b-
catenin are functionally interchangeable [3,4,5,6,7]. If so, this
might allow for a Wnt ligand-independent induction of Wnt target
genes, whereby b-catenin released from the membrane is used
directly for signalling. In support of this idea, it has recently been
shown in a cancer cell line that dissociation of adherens junctions
by lysophosphatidic acid results in a release of b-catenin, which, in
a mutated stabilised form, translocates into the nucleus [8].
However, it is not known whether this occurs with native b-
catenin. This utilisation of cadherin-bound b-catenin in Wnt
signalling is interesting, as cadherins are generally considered
negative regulators of the pathway, through their sequestration of
b-catenin, and it has been shown that increased and decreased
levels of cadherin expression inhibit and activate b-catenin-
dependent transcription, respectively [9,10,11,12,13,14,15].
The concept of ligand-independent Wnt signalling is further
suggested by the fact that in some developmental situations there
appears to be no obligate correlation between Wnt ligand
expression and Wnt pathway activation. This is the case for
migrating neural crest cells; despite not expressing any known Wnt
ligand, the Wnt pathway is active in these cells [16] and is required
for them to form cranial ganglia [17]. Another example is
gastrulation, where epiblast cells delaminate and migrate laterally
to form paraxial mesoderm. Wnt/b-catenin activity is required in
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these migrating cells in order for them to contribute to the
mesoderm; in mouse embryos harbouring mutations in either
Wnt3a or the Wnt-regulated mesodermal transcription factor
Tbx6, these delaminated cells form additional neural tubes instead
of somites [18,19]. This Wnt activity requirement occurs in the
absence of any significant upregulation of Wnt ligand expression.
Importantly, both of these events see cells undergoing epithelial-
mesenchymal transition (EMT), a process involving dissociation of
adherens junctions and changes in cell morphology. The above in vivo
events could, therefore, be explained by an alternative phenomenon:
differential sensitivity to Wnt signals between epithelial and
mesenchymal cells. Compared to epithelial cells, mesenchymal cells
generally exhibit a much less regimented structure and weaker
intercellular adhesion. Thus, it is possible that the cytoarchitectural
changes that occur at EMT render the mesenchymally transformed
cells more sensitive to Wnt signals originating from neighbouring
tissue, the Wnt ligand-expressing ectoderm in the cases of migrating
neural crest and mesodermal cells.
To gain more insight into the relationship between the two
functions of b-catenin, and to explore how cellular changes at
EMT affect the signalling capacity of b-catenin we used two
models of EMT: hepatocyte growth factor (HGF) treatment of
MDCK cells, and gastrulation in embryonic development. We
find that cadherins do not merely provide a pool of b-catenin
capable of feeding into the Wnt pathway, but rather play a positive
role in rendering b-catenin competent in signalling.
Results
Mesenchymal Cells Show an Enhanced Wnt
Transcriptional Response Compared to Epithelial Cells
For studying the Wnt signalling pathway, HEK293 cells are
widely used as they are very responsive to exogenous Wnt ligands
and transfected b-catenin, as judged by activation of the established
b-catenin/LEF/TCF reporter TOPflash (Fig. 1A). In contrast,
MDCK cells hardly respond to Wnt3a medium, and show only a
mild activation by b-catenin transfection (Fig. 1A). HEK293 cells
andMDCK cells are morphologically distinct. Although epithelial in
origin, HEK293 cells grow in a flattened and scattered manner
(Fig. 1B), while MDCK cells maintain typical epithelial features such
as apical-basal polarity, tight junctions and adherens junctions [20]
and display a cobblestone-like appearance (Fig. 1C). This tightly
compacted epithelial morphology of MDCK cells can be converted
to a mesenchymal one by treatment with HGF, which causes a
breakdown of intercellular junctions and an acquisition of cell
motility, processes typical of EMT [21,22] (Fig. 1D). It has previously
been reported that HGF treatment causes mild activation of
TOPflash in MDCK cells [23], which we confirmed (Fig. 1E,F).
Notably, when MDCK cells are transformed to a mesenchymal
morphology by HGF before being treated with Wnt3a, the Wnt
pathway readout is significantly enhanced (Fig. 1E). This is also the
case for b-catenin transfection; HGF treatment significantly
augments the effect of exogenous b-catenin (Fig. 1F). These results
suggest that fundamental changes that occur when a cell switches
from an epithelial to a mesenchymal morphology facilitate the
activation of the Wnt pathway, not only in response to Wnt signals
but also to exogenous b-catenin.
HGF-induced EMT of MDCK Cells Results in Redistribution
of b-catenin from the Membrane to the Cytoplasm and
Causes Activation of Wnt-responsive Genes
In MDCK cells, b-catenin is predominantly at the membrane,
where it colocalises with E-cadherin (Fig. 2A,B). Treating cells
with HGF causes cells to flatten and scatter, and induces
redistribution of both b-catenin and E-cadherin to the intracellular
space, which commences within 4 hours (Fig. 2C,D) and is fully
attained by 16 hours (Fig. 2E,F). This process is likely mediated by
activation of Src tyrosine kinase and the subsequent phosphory-
lation of E-cadherin, which leads to dissociation of catenins from
the cadherin complex and breakdown of the adherens junction
[24]. Immunocytochemical analyses revealed that E-cadherin is
largely distributed in a punctate manner in HGF-treated MDCK
cells (Fig. 2C–F), which is in agreement with previous studies
showing that internalised E-cadherin is, upon src-mediated EMT,
located in the endosome and subsequently in the lysosome for
degradation or recycling [25] (see also Fig. 3F). We found that b-
catenin tends to accumulate at a perinuclear location, as reported
in other systems [26], although not in a punctate manner
(Fig. 2D9,2F9) and hence not exactly colocalising with E-cadherin
in the cytoplasm. Cell fractionation analyses show that E-cadherin
is always detected in the insoluble fraction (membrane fraction
including endosomal vesicles) and not in the cytosolic fraction even
after HGF treatment, while b-catenin in the cytosolic fraction
increases in response to HGF treatment at 6 and 16 hours
(Fig. 2G,H). Thus, it appears that once E-cadherin is internalised
by HGF stimulation, b-catenin is dissociated from the cadherin
complex and becomes abundant in the cytosol, while E-cadherin
remains in membrane vesicles. The increase of b-catenin in the
cytosolic fraction by HGF is seen both in the absence and presence
of cycloheximide at the 6 hour time point (Fig. 2H), suggesting
that, at least within the initial 6 hours, this increase is not due to de
novo b-catenin synthesis, but rather to a possible movement of pre-
existing b-catenin from the membrane to the cytosol. We did not
detect a reduction in b-catenin in membrane fraction after HGF
treatment, presumably due to the relatively large amount in the
membrane fraction.
To test whether the HGF-induced EMT causes activation of
Wnt target genes, we looked at the expression levels of both the
potential endogenous target MMP-13 [27,28] and the transfected
TOPflash reporter in MDCK cells treated with cycloheximide for
6 hours and/or HGF using quantitative RT-PCR, and found that
HGF increases the transcription of these genes even in the
presence of cycloheximide (Fig. 2I). The increase in expression of
these transcripts by HGF was slightly higher in the presence of
cycloheximide than in the absence of cycloheximide, possibly due
to a block of negative feedback mechanisms that are often in
operation in Wnt/b-catenin signalling. These results agree with
the idea that b-catenin in the membrane pool is likely to contribute
to the transcriptional activation of Wnt target genes upon HGF
treatment.
Endocytosis is Required for HGF’s Stimulation of
Canonical b-catenin Signals
To verify the shift of b-catenin from the membrane to the
cytoplasm, we examined the role of endocytosis. E-cadherin
undergoes a dynamic turnover; it is continuously internalised in a
Dynamin- and Rab5-dependent manner, then is either recycled to
the cell surface or degraded [29,30,31,32]. Following activation of
tyrosine kinases such as Src and the HGF receptor c-Met, the
cytoplasmic tail of E-cadherin is phosphorylated, which directs
internalised E-cadherin to lysosomal degradation [21,25]. Con-
currently, b-catenin is also phosphorylated at specific tyrosine
residues, particularly at Y142 and Y654, which reduces its affinity
for a-catenin and E-cadherin, respectively [33,34,35], resulting in
breakdown of the cadherin complex intracellularly. To examine
the requirement of endocytosis, we used dynasore, a potent
inhibitor of dynamin-dependent endocytosis [36]. Dynasore
treatment alone does not affect the amount of cytosolic b-catenin
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Figure 1. Mesenchymal cells show strong Wnt transcriptional response compared to epithelial cells. (A) TOPflash reporter assay in
HEK293 and MDCK cells treated with 250 ng/ml HGF or Wnt3a conditioned medium, or transfected with b-catenin. HGF causes mild activation of
TOPflash in MDCK cells. HEK293 cells exhibit an enhanced Wnt transcriptional readout relative to MDCK cells. (B–D) Appearance of HEK293 cells (B),
MDCK cells (C) and MDCK cells treated with HGF for 16 hours (D). MDCK cells scatter and adopt a mesenchymal morphology akin to HEK293 cells
following HGF treatment. Scale bar; 50 mm. (E) TOPflash reporter assay in MDCK cells treated with HGF or Wnt3a alone, or pre-treated with HGF for
8 hours before exposure to Wnt3a. HGF treatment augments the transcriptional response to Wnt3a. (F) TOPflash reporter assay in MDCK cells treated
with HGF or transfected with b-catenin alone, or transfected with b-catenin and treated with HGF for the final 16 hours before harvesting. HGF
treatment augments the transcriptional response to transfected b-catenin.
doi:10.1371/journal.pone.0023899.g001
A Role of Cadherin in Wnt Signalling
PLoS ONE | www.plosone.org 3 August 2011 | Volume 6 | Issue 8 | e23899
A Role of Cadherin in Wnt Signalling
PLoS ONE | www.plosone.org 4 August 2011 | Volume 6 | Issue 8 | e23899
in MDCK cells after 16 hours (data not shown), but does block the
HGF-dependent increase of b-catenin in the cytosol, both at 6 and
16 hours (Fig. 3A). Dynasore does not affect HGF signalling per se,
as revealed by Erk phosphorylation (Fig. 3B), or general
transcriptional activity, as measured by Renilla luciferase in the
control of the reporter assay (data not shown). Immunocytochem-
ical analyses showed that upon HGF treatment for 6 or 16 hours, E-
cadherin partially colocalises with endocytosed transferrin receptor
(Fig. 3F and data not shown). In the presence of dynasore, however,
internalisation of E-cadherin is blocked and both b-catenin and E-
cadherin remain at the cell membrane (Fig. 3G,H and data not
shown). Under these conditions, Wnt pathway readout by both
HGF and HGF in combination with b-catenin is significantly
reduced (Fig. 3I), suggesting requirement of endocytosis for b-
catenin to activate transcription in response to HGF. It is noted that
the susceptibility of overexpressed b-catenin to endocytosis
inhibition is observed not only in the condition where HGF and
Dynasore are applied simultaneously (Fig. 3I), but also when cells
are pre-treated with HGF for 24 hours (and are hence transformed
to a mesenchymal morphology) before the addition of Dynasore
(Fig. 3M). This suggests that endocytosis is required not merely for
HGF to carry out an immediate effect, but also for augmented
activation of the Wnt/b-catenin pathway in pre-transformed cells.
One possible mechanism for the requirement of endocytosis is
the release of b-catenin from E-cadherin following internalisation
of the complex, where HGF stimulates the mobilisation of b-
catenin from the membrane. It is worth noting that following
transfection of b-catenin DNA, exogenous b-catenin is found in the
cytoplasm in cells treated with HGF, regardless of absence or
presence of dynasore (Fig. 3K,L). Nevertheless, dynasore-treated
cells show only weak transcriptional activation after b-catenin
transfection (Fig. 3I), suggesting that a large proportion of
overexpressed b-catenin is susceptible to the inhibition of
endocytosis. Thus, it seems that it is not stability or availability
in the cytoplasm, but rather the process of localising to the
membrane and then being endocytosed, that is crucial for the
transcriptional activity of b-catenin. This is supported by the
finding that there is no significant difference in the TOPflash
readout in MDCK cells transfected with full length b-catenin and
those with a constitutively-active non-degradable form of b-
catenin, at least when cells have an epithelial morphology or are
lacking E-cadherin (see Fig. 5G). Another possible mechanism is
the involvement of factors sensitive to endocytosis inhibition that
are required for the transcriptional activity of b-catenin. In either
case, our results underscore the importance of cellular endocytosis
processes in transcriptional activation by b-catenin and show that
the availability of b-catenin in the cytosol does not necessarily
reflect its transcriptional activity.
Ability to bind cadherin is required for b-catenin’s
transcriptional activity
We next wanted to test whether the augmented activation of b-
catenin-dependent signalling by endocytic processes requires the
endocytosis of the E-cadherin/b-catenin complex itself. For this
purpose we used various mutant forms of b-catenin that show
different affinities for its binding partners of the adhesion complex.
The cadherin-catenin complex is a substrate for tyrosine kinases,
suggesting phosphorylation as a potential mechanism for regulat-
ing the state of the complex [33]. It has been shown that these
phosphorylation events are primarily involved in the regulation of
adherens junction integrity and cell-cell adhesion
[34,35,37,38,39], and that phosphomimetic and phospho-resistant
forms of b-catenin affect its transcriptional activity in various cell
types [34,38,39]. For example, the Y654E mutation reduces the
affinity of b-catenin to cadherins [35], whereas Y142E b-catenin
has a reduced affinity for a-catenin [38]. Although both of the
forms are defective in forming the cadherin-catenin-cytoskeleton
complex, the former does not bind to cadherin while the latter
does.
When transfected into MDCK cells, exogenous wild type b-
catenin localises predominantly at the membrane, where it
colocalises with E-cadherin (Fig. 4A,B; see also Fig. 3J). Among
11 mutant forms of b-catenin, only Y654E does not localise at
the membrane, but is instead widely expressed throughout the
cytoplasm (Fig. 4A,B). This is in agreement with the reduced
affinity of Y654E to cadherins [35]. Remarkably, only this
mutant is less able to induce TOPflash expression compared
with wild type and other mutated forms of b-catenin (Fig. 4C),
suggesting that the ability of b-catenin to bind to cadherins is
crucial for its transcriptional activity. Moreover, addition of
HGF to the medium sustains the relative trend of TOPflash
activities in all tested constructs including the low activity of
Y654E, despite augmented activities as a whole (Fig. 4D).
Hence it appears that the crucial event in the augmented
transcriptional activity of b-catenin during EMT is the process
of b-catenin binding to cadherin and subsequently detaching
from it, the latter of which is initiated by endocytosis. This also
implies that b-catenin derived from the cadherin complex may
be distinct from a newly translated b-catenin that has never
bound to cadherin; the former can provide transcriptional
activation of the Wnt pathway while the latter cannot. It is as if
b-catenin is somehow primed for transcriptional activity by
undergoing interaction with and detachment from cadherin.
The priming effect is yet to be clarified, but at least it does not
appear to be phosphorylation of Y654. The result also confirms
that the mere availability in the cytoplasm is not sufficient in
MDCK cells.
Figure 2. HGF-induced EMT of MDCK cells induce redistribution of b-catenin and causes activation of Wnt-responsive genes. (A–F)
Confocal microscopy of MDCK cells showing b-catenin (red), E-cadherin (green) and nucleus (blue) after HGF treatment as indicated. Without HGF
(A,B), b-catenin is mostly co-localised with E-cadherin at the cell membrane. HGF treatment causes flattening and spreading of cells (C–F), along with
internalisation of b-catenin and E-cadherin. Although both E-cadherin and b-catenin are mainly localised in a perinuclear region, they are not strictly
colocalised, as internalised E-cadherin is seen in a punctate manner while b-catenin is distributed relatively broadly. Scale bars, 20 mm. (G) Western
blot analyses of cytosolic and membrane fractions of MDCK cells after treatment with HGF. b-catenin is present in the cytosolic fraction at a low level
in untreated MDCK cells, and is increased by HGF treatment. E-cadherin is detectable only in the membrane fraction, as is transferrin receptor (loading
control). The amount of E-cadherin increases consistently in the membrane fraction following HGF treatment. b-tubulin serves as a loading control of
the cytosolic fraction. (H) Western blot analyses of MDCK cells showing that cytosolic b-catenin increases in response to HGF both in the absence and
presence of cycloheximide (CHX). (I) The relative levels of Wnt target genes (transfected TOPflash reporter and endogenous target MMP-13) are
increased by 4 hours of HGF treatment both in the absence and presence of cycloheximide (CHX) as shown by quantitative PCR. In the condition with
no CHX, P-values were P,0.001 for MMP13 and P=0.046 for TOPflash luciferase. In the condition with CHX, P,161025 for MMP-13, P,0.002 for
TOPflash luciferase.
doi:10.1371/journal.pone.0023899.g002
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Cadherin is required for the increase in cytoplasmic
b-catenin and for transcriptional activation in response
to Wnt and b-catenin
As the above results suggest that the cadherin complex functions
positively on b-catenin for activation of the Wnt pathway, we next
examined Wnt pathway activation in the absence of E-cadherin.
We used an MDCK cell line which stably carries an E-cadherin
shRNA-expressing construct that is inducible by a Tet-ON system
[40]. Depletion of E-cadherin was confirmed by Western blots
(Fig. 5F). E-cadherin depletion in MDCK cells does not
compromise cell adhesion or localisation of b-catenin at the cell
membrane, presumably due to endogenous Cadherin-6 expression
[41], although cells are slightly flattened (Fig. 5A,C). HGF causes
further flattening of cells in the absence of E-cadherin (Fig. 5C,D).
However, the majority of b-catenin remains at the cell membrane
while the minority distributes in the cytoplasm in a punctated
manner, different from the cells with E-cadherin (Fig. 5B,D). This
suggests that intracellular translocation of b-catenin and its
following distribution into the cytosol in response to HGF depends
on internalisation with E-cadherin. A possibility remains that a
depletion of E-cadherin might affect subcellular distribution of
HGF receptor c-Met which is often associated with E-cadherin
[42,43] thus resulting in reduced HGF signalling. However, a
complete blockage of HGF signalling is unlikely as cells do respond
to HGF and show morphological changes (Fig. 5C,D).
In the TOPflash assay, HGF stimulation failed to activate the
reporter in E-cadherin depleted cells (Fig. 5E). In addition, the
response to both Wnt3a medium and b-catenin transfection is
markedly impaired, suggesting a requirement for E-cadherin for b-
catenin’s transcriptional activity in MDCK cells. We further
investigated whether E-cadherin knockdown affects the stability of
cytosolic b-catenin by immunoblotting for the ‘active’ form of b-
catenin in E-cadherin depleted cells following stimulation of the
Wnt pathway by various methods such as treatment with Wnt3a
or the GSK3b inhibitor BIO and transfection of b-catenin (Fig. 5F).
The active form of b-catenin is detected by ABC antibody, which
specifically recognises b-catenin that has not been phosphorylated
by GSK3b at specific serine and threonine residues, and is hence
not tagged for degradation [44]. Addition of Wnt3a or BIO in the
medium causes an increase of active b-catenin, which is enhanced
by addition of HGF (Fig. 5F). HGF also increases the amount of
exogenous myc-tagged b-catenin that is found in the cytosol after
transfection, and this corresponds with an increase in the
immunoreactivity to ABC antibody, in agreement with the above
TOPflash result (Fig. 5E,F). However, upon E-cadherin depletion,
the ability of HGF to increase the active form of b-catenin is
abolished in all conditions (Fig. 5F). In the immunocytochemical
analysis, exogenously transfected b-catenin was found to be
abundant in the cytoplasm in E-cadherin depleted cells in the
presence of HGF, similar to parental MDCK cells treated with
HGF (Fig. 5C9, D9), supporting the idea that availability of b-
catenin in the cytoplasm does not reflect pathway activation. To
further confirm the requirement for E-cadherin in b-catenin-
dependent activation of the Wnt pathway, we used a mutated form
of b-catenin that is resistant to degradation, and thus stable in the
cytoplasm [45]. This stable form, in which four serine/threonine
residues at the amino-terminal end are mutated to alanine (b4A),
does not show any significant difference in TCF/LEF-dependent
transcription compared to wild type b-catenin in MDCK cells in
the absence of E-cadherin (Fig 5G), whereas the difference is
noticeable in the presence of E-cadherin and HGF (Fig. 5G) and
more pronounced in HEK293 cells (data not shown). However
when E-cadherin is depleted, the stable form of b-catenin failed to
activate the TOPflash reporter both in the absence and presence
of HGF (Fig. 5G).
Collectively, these results show that E-cadherin is required for
the augmented activation of the Wnt pathway in MDCK cells
during HGF-dependent transformation. One might argue that
attenuated TOPflash activity after E-cadherin depletion is due to
failure of EMT, thereby keeping cells epithelial-like, the feature
that renders cells less responsive to Wnt pathway activation (Fig. 1).
The question, therefore, is what is the epithelial feature that
prevents cells from activating the Wnt pathway? Our results of
depletion of E-cadherin in the absence of HGF suggest that it is
not E-cadherin that is responsible for preventing activation in
epithelial cells (Fig. 5A,C,E), since depletion of it reduces
activation, rather than enhancing it. Perhaps in MDCK cells,
the cadherin complex serves as a pool of b-catenin, while
exogenously overexpressed cadherins sequester b-catenin
[9,10,11,13,14,15]. Figure 5E together with Figure 3 clearly show
that the effect of transfected b-catenin is most significant when E-
cadherin is present and the cadherin complex undergoes
internalisation. Therefore, the crucial events for b-catenin’s
activity seem to be firstly interacting with E-cadherin, either upon
trafficking at ER/Golgi or transiently at the membrane, and
second, becoming available in the cytoplasm. The latter step alone
without a preceding interaction with cadherin does not provide
transcriptionally active b-catenin even if it becomes abundant in
the cytoplasm (Fig. 5D9). Our results also suggest that EMT in
MDCK cells relies on an intact E-cadherin-based adhesion system
Figure 3. Stimulation of b-catenin signals by HGF is dependent on endocytosis. (A) Western blot analyses of the cytosolic fraction of MDCK
cells after treatment with HGF and increasing amounts of Dynasore (50, 100, 200 and 400 mM) for 6 and 16 hours shows a dose-dependent reduction
in cytosolic b-catenin accumulation by HGF. (B) Western blot analysis of cytosolic fraction of MDCK cells after treatment with HGF and Dynasore (100
and 400 mM) for 30 minutes. Blocking endocytosis by Dynasore does not interfere with HGF signalling-induced phsophorylation of Erk (p-Erk). (C–H)
Confocal microscopy of MDCK cells showing E-cadherin (green) and either b-catenin (red in C,E,G) or transferrin receptor (red in D,F,H) after treatment
with HGF without or with Dynasore (400 mM) for 16 hours. In the absence of HGF or Dynasore (C,D), b-catenin and E-cadherin are localised at the cell
membrane (C, also shown in Fig. 2A,B) while transferrin receptor is mostly in the subcortical area (D). HGF treatment (E,F) causes internalisation of b-
catenin and E-cadherin (E, also shown in Fig. 2E,F) and movement of transferrin receptor to a perinuclear location, where it colocalises with
internalised E-cadherin (F). In the presence of Dynasore, the ability of HGF to induce internalisation of b-catenin and E-cadherin is abolished, and they
both remain at the cell membrane (G). Scale bars; 20 mm. (I) TOPflash reporter assay in MDCK cells with control (c) or b-catenin (b-cat) transfection
and HGF treatment (similar to Fig. 1F), in the absence or presence of Dynasore (400 mM). There is a reduction in Wnt pathway readout by both HGF
and HGF plus b-catenin in the presence of Dynasore. HGF and Dynasore were added to transfected cells for the final 16 hours of incubation. Data
were all normalised to the control without Dynasore. (J–L) Confocal microscopy of MDCK cells transfected with Flag-tagged b-catenin (red), treated
with HGF and Dynasore as indicated, counterstained with DAPI (blue). Exogenous b-catenin is localised at the cell membrane in the absence of HGF
(J), whereas HGF-treated cells show exogenous b-catenin in the cytoplasm, both in the absence (K) and presence (L) of Dynasore. Scale bar; 20 mm.
(M) TOPflash reporter assay in MDCK cells with b-catenin transfection and HGF and Dynasore (200 mM) treatment. Where applicable, HGF were first
added to cells for 24 hours to make cells mesenchymal, before adding Dynasore for 16 hours (total 40 hours of HGF). Dynasore attenuates the effect
of transfected b-catenin in the mesenchymally transformed cells. *P=0.011. (N) Schematic diagram summarising the requirement for the release of an
active form of b-catenin into the cytosol.
doi:10.1371/journal.pone.0023899.g003
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and that HGF is unlikely to be able to induce cadherin-6
internalisation in a similar fashion to E-cadherin. These results
highlight the fact that the ability of Wnt signals and exogenous b-
catenin to activate transcription differs depending on the cellular
context such as epithelial versus mesenchymal morphology and
presence versus absence of E-cadherin. In other words, there are
differences in the ability of cells to utilise b-catenin for
transcription when it becomes available.
Requirement for cadherins in activating the Wnt pathway
in vivo
The above data suggest that cadherins are positive regulators of the
Wnt pathway in two ways: by providing a pool of b-catenin and by
rendering b-catenin competent in signalling. We wanted to examine
whether this positive role is also true in in vivo settings. However, the
fundamental role for E-cadherin in constructing and maintaining
tissue structures impeded us to analyse the requirement of E-cadherin
in vivo. In addition, although E-cadherin expression in MDCK cells is
maintained during EMT, in in vivo contexts cells often switch the
expression of cadherin types at the event of EMT. For example, in
mouse 8.5 dpc embryos, epiblast cells forming the epithelial layer
expresses E-cadherin, whereas the cells undergoing EMT in the
primitive streak switch off E-cadherin and turn on N-cadherin [46].
These delaminated cells migrate laterally and differentiate into
mesoderm. Notably, Wnt/b-catenin activity is known to be required
for the ingressing cells to differentiate into mesoderm [19,47],
although ligand expression, such as of Wnt3a and Wnt8, is rather
down-regulated upon delamination [19,48]. We speculated that
Wnt/b-catenin activity in cells undergoing EMT in this context is
augmented by cadherin, particularly by N-cadherin which is
expressed in cells becoming mesoderm during the whole process of
ingression until they are re-epithelised to form somites [46,49].
As N-cadherin has distinct features from E-cadherin [50,51], we
first confirmed a positive role for N-cadherin in the transcriptional
activity of b-catenin in vitro, using HEK293 cells, which strongly
express N-cadherin (Fig. 6A,B). In the presence of N-cadherin
siRNA, the transcriptional activity of b-catenin is significantly
attenuated (Fig. 6A,B), supporting the requirement for cadherin in
Wnt signalling.
We next analysed Wnt signalling readout in N-cadherin deleted
mouse embryos [52,53]. In the background of the TOP-LacZ
reporter [54], N-cadherin-deleted mouse embryos show a
significantly lower expression of the reporter in the posterior
region, both in the delaminating cells at the midline of the epiblast
and in laterally migrating mesodermal cells, while other regions
such as the differentiating somites and the midbrain show
comparable levels of reporter expression to that of N-cadherin
+/+ embryos (n = 8 for each; Fig. 6C–F). In support of the reduced
Wnt activity, the expression of Tbx6, a Wnt/b-catenin target gene
required for mesodermal differentiation [18,37,47,55,56], was also
attenuated in N-cadherin-deleted embryos (n = 4, Fig. 6G–J). Thus
the positive regulation of the Wnt/b-catenin pathway by cadherin
is not merely an in vitro phenomenon, but one that could affect
signalling in vivo.
In summary, we have shown that (1) cadherins maintain a pool
of b-catenin that can be made available for signal transduction
upon EMT; (2) mesenchymally transformed cells are highly
responsive to Wnt ligands and overexpressed b-catenin in the
activation of the Wnt pathway; (3) the internalisation process,
presumably that of the cadherin complex, is a prerequisite for the
augmented activation upon EMT; and (4) cadherins are required
for and play an instructive role in providing b-catenin for Wnt
signalling, such that binding of b-catenin to cadherins renders b-
catenin competent in the Wnt pathway.
Discussion
In an effort to obtain in vitro data to explain the potential in vivo
phenomenon of ligand-independent Wnt pathway activation, we
have found that conversion of epithelial cells to a mesenchymal
morphology activates the Wnt pathway in two ways. Firstly, as an
immediate response, the conversion is associated with an increase
of b-catenin in the cytosol, where it then becomes available to
activate target genes, which we show to be dependent on
endocytosis and independent of protein synthesis. Secondly, we
show that the cellular changes that occur at EMT augment Wnt
pathway readout by exogenous Wnt ligand and transfected b-
catenin, and that this augmentation also requires intact endocytic
processes. Moreover, we also find that cadherins play a positive
role in b-catenin-dependent transcription: it is crucial for b-catenin
to bind cadherin in order to activate downstream genes; b-catenin
with reduced affinity for E-cadherin (the Y654E mutant) shows
impaired activation of transcription, while loss of E-cadherin
reduces Wnt transcriptional readout by both Wnt3a ligand and
transfected b-catenin. Requirement of cadherins is further verified
in an in vivo context, where knockout of N-cadherin leads to
reduced Wnt pathway activity in ingressing cells during gastrula-
tion.
Mobilisation of b-catenin from cell membrane for use in
signalling
We have shown that cells with distinct epithelial features are
refractory to exogenous Wnt signals, in comparison to mesenchy-
mal-like cells, but that their conversion to mesenchyme by HGF
greatly facilitates the utilisation of b-catenin for signalling. This
stimulation of canonical b-catenin signals by HGF, and the
subsequent increase in transcriptional readout at the immediate-
early stage, appears to be a result of movement of pre-existing b-
catenin from the membrane to the cytoplasm, since it occurs
independently of protein synthesis. This supports previous studies
that suggest that b-catenin from the membrane can enter the
nucleus and be used for transcription [8,57], and puts forward a
potential ligand-independent explanation for the lack of obligate
correlation between Wnt ligand expression and Wnt pathway
activation [16,17,19,58]. Our results are also consistent with the
observation that cell density affects the expression of E-cadherin as
well as subcellular localisation of b-catenin [59], and that
dissociation of cells in a low calcium condition in vitro causes an
Figure 4. A form of b-catenin that does not localise to the cell membrane shows low transcriptional activity. (A) Fluorescent microscopy
of MDCK cells immunostained for transfected Flag-tagged b-catenin of wild type (WT) and various mutant forms as indicated. Exogenous b-catenin,
detected by anti-Flag antibody, is localised to the cell membrane, except for the Y654E mutant, which shows cytoplasmic distribution. Scale bar,
20 mm. (B) Similar analyses as (A), with co-staining with E-cadherin (red) and nuclei (blue). Wild type b-catenin co-localises with E-cadherin, whereas
Y654E does not. Scale bar, 20 mm. (C, D) TOPflash reporter assay of the b-catenin mutants in MDCK cells, without (C) or with (D) HGF in the medium.
The fold activation was normalised against cells transfected with control DNA without HGF treatment. Transcriptional activation is similar amongst all
the constructs with the exception of Y654E, which gives a much-reduced transcriptional readout (*P,261027 compared to other b-catenin
constructs) in both conditions.
doi:10.1371/journal.pone.0023899.g004
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increase of cytosolic b-catenin in an ‘active’ form [60]. We find
that the stimulation of b-catenin signals from the membrane is
dependent on endocytosis, as treatment with the dynamin
inhibitor dynasore attenuates augmentation of b-catenin-depen-
dent transcription by HGF. We speculate that endocytosis in this
EMT model is required at least for the turnover of E-cadherin and
the dissociation of b-catenin from recently endocytosed E-
cadherin, not only at the immediate-early stage but also when
cells have become mesenchymal (Fig. 3). Interestingly, a study
showed a requirement for endocytosis in the cadherin-free L cell
line for stabilisation of b-catenin and activation of the TOPflash
reporter in response to Wnt and lithium [61]. The exact role of
endocytosis in the Wnt pathway has yet to be clarified, particularly
with respect to the identity of what needs to be endocytosed, given
the lack of cadherins in L cells, and how direct inhibition of
GSK3b by lithium requires intact endocytosis processes.
EMT facilitates activation of the Wnt pathway by Wnt
signals
In addition to describing the mobilisation and transcriptional
utilisation of b-catenin from the membrane, we demonstrate
another fundamental cell biological phenomenon: that the cellular
alterations occurring at EMT augment Wnt pathway readout in
response to exogenous Wnt ligand and transfected b-catenin. The
result that transfected b-catenin shows high transcriptional activity
in cells that have undergone EMT, together with the results that
both inhibition of internalisation and depletion of endogenous
cadherin abolish the augmentation despite the presence of b-
catenin in the cytoplasm, implies control at the subcellular, rather
than extracellular, level. The increase in E-cadherin internalisation
at EMT [21,43] is one mechanism which might facilitate
activation of the Wnt pathway, since it not only provides, but
also augments, by increased turnover, a pool of signalling-
competent b-catenin.
Availability of b-catenin in the cytoplasm and pathway
activation
It might be tempting to suggest that HGF potentiates
transcriptional activity of b-catenin by increasing its stability.
HGF does indeed increase the amount of stable b-catenin in the
cytosol, as detected by ABC immunoblotting, and this is reflected
in the augmented activity of TOPflash (Fig. 5). However, HGF
also increases the total cytosolic b-catenin (Fig. 2,5), and hence we
have yet to determine whether the absolute ratio of stable:total b-
catenin increases or whether HGF specifically increases the
stability of b-catenin by preventing it from being phosphorylated.
The destruction complex component APC is generally high in
epithelial MDCK cells [62] and we did not detect any change in
APC levels by HGF treatment (data not shown). In fact it has been
reported that APC levels increase in HGF-treated cells relative to
untreated cells [63]. It is also possible that HGF treatment caused
a decrease in the level of GSK3b [64] or an increase in the levels
of Ras or PI 3-kinase [65,66,67], all of which would increase the
stability of cytosolic b-catenin. In our study, HGF augments
transcriptional activity of exogenous b-catenin in both its native
and stable forms, suggesting that this is a stability-independent
event (Fig. 5G). In addition, the stable form of b-catenin is not
active in MDCK cells in the absence of HGF (Fig. 5G). These
results suggest that the role of HGF is not to specifically increase
the stability of b-catenin. The findings that the effect of HGF is
dependent upon endocytosis (Fig. 3) and E-cadherin (Fig. 5) also
suggest that a direct stabilising function is unlikely. In support of
the idea that stabilisation of b-catenin is not the sole determinant
in its transcriptional activity, we show that in some experimental
situations saturation of the cytoplasm with b-catenin is not
reflected by an increase in transcriptional readout (Figs. 3I,L, 4).
Similarly, it has been shown that increased cytosolic pools of b-
catenin are not the cause of translocation into the nucleus in the
case of melanoma cells [62]. These findings could have far-
reaching implications, since it has always been considered that the
key step in the Wnt pathway is regulation of the cytosolic pool of
b-catenin that is available to enter the nucleus and thereby
modulate transcription. One remaining possibility is that HGF
potentiates transcriptional activation by inducing dissociation of b-
catenin from a-catenin through ERK signalling [68]. However,
our result that ERK phosphorylation is not affected by dynasore,
while b-catenin’s transcriptional activity is, suggests that the effect
is ERK-independent.
Requirement of cadherins in Wnt/b-catenin signalling
The result that cadherins are required for activation of the Wnt
pathway, both in MDCK (Fig. 5) and HEK293 cells (Fig. 6B), was
an unexpected one, given that cadherins are generally considered as
negative regulators of Wnt pathway activation through sequestra-
tion of b-catenin. Indeed, forced overexpression of cadherins has
been found to antagonise Wnt/b-catenin signalling in Xenopus,
Figure 5. Cadherins are required for transcriptional activation by Wnt3a and b-catenin. (A–D) Confocal microscopy of MDCK cells without
(control, 2Tet) or with (+Tet) induction of E-cadherin shRNA expression by tetracycline, after treatment without or with HGF, stained for b-catenin.
Insets in (C) and (D) (C9,D9) are exogenous b-catenin detected by myc tag. For the exogenous b-catenin in the presence of E-cadherin, see Fig. 3J,K. E-
cadherin-depleted cells do not scatter by HGF and the majority of b-catenin remains on the cell membrane, while the minority distributes in the
cytoplasm in a punctuated manner. Transfected b-catenin localises at the cell membrane in the absence of HGF (C9), while it distributes in the
cytoplasm in the presence of HGF (D9), similar to E-cadherin-positive MDCK cells (see Fig. 3J,K). Scale bar, 20 mm. (E) TOPflash reporter assay in MDCK
cells (control, 2Tet) or MDCK cells depleted of E-cadherin (E-cadherin shRNA, +Tet). Cells transfected with TOPflash reporter were either treated with
Wnt3a medium or co-transfected with b-catenin. Treatment of cells with HGF enhances cells’ response to Wnt3a or b-catenin, as seen in Fig. 1E and
1F. In cells depleted of E-cadherin, HGF fails to enhance the response to Wnt3a and b-catenin. (F) Western blot analysis of membrane (upper two
rows) and cytosolic (lower four rows) fractions of MDCK cells without or with induction of E-cadherin shRNA expression, without or with HGF. Some
groups of cells were treated with Wnt3a conditioned medium or with 2 mM BIO, a GSK3b inhibitor, or transfected with myc-tagged b-catenin, as
indicated at the top. The membrane fraction analysis shows that E-cadherin shRNA completely abolishes E-cadherin protein. The cytosolic fraction
was analysed with anti-Active-b-catenin (ABC) and anti-b-catenin (total) antibodies, along with anti-myc antibody to detect exogenous b-catenin and
with anti-b-tubulin for loading control. Cell lysate of A431 human carcinoma was used as a positive control for anti-active-b-catenin antibody. In all
experimental groups, active-b-catenin is increased in response to HGF when E-cadherin expression is kept intact. In contrast, in the absence of E-
cadherin the ability of HGF to increase active-b-catenin is abolished. Note that myc-tagged b-catenin, larger than endogenous one in size, is also
detected by ABC antibody, responding to HGF and to the loss of E-cadherin in a manner similar to endogenous ones treated with Wnt3a or BIO. (G)
TOPflash reporter assay in MDCK cells (control, 2Tet) or MDCK cells depleted of E-cadherin (E-cadherin shRNA, +Tet). Cells were transfected with
TOPflash reporter along with b-catenin (b-cat) or the stabilised form in which four serine and threonine residues of GSK3b targets have been mutated
to alanine (b4A) [45]. Similar to b-catenin, b4A construct does not show any significant activation of the reporter in E-cadherin-depleted cells,
regardless of presence or absence of HGF.
doi:10.1371/journal.pone.0023899.g005
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Figure 6. N-cadherin-deleted mouse embryos show low Wnt pathway activity and reduced downstream target gene expression
during EMT. (A) Western blot analysis of membrane fraction of HEK293 cells transfected with control or N-cadherin siRNA. Transferrin receptor
serves as a loading control. N-cadherin siRNA attenuates N-cadherin expression. b-catenin is also slightly reduced. (B) TOPflash reporter assay in
HEK293 cells, after transfection of N-cadherin siRNA. Cells were either treated with control medium (C) or Wnt3a medium (W), or transfected with b-
catenin (b). N-cadherin siRNA attenuates the effect of b-catenin transfection. *P,161026. (C–F) TOP-LacZ reporter mouse embryos at 8.5 dpc with
genotypes of wild type (+/+) or deleted (2/2) N-cadherin. The reporter expression is detected by an in situ hybridisation probe against LacZ. At the
level of the primitive streak in the posterior region (arrowheads in C,D), the reporter expression is much weaker in the 2/2 mutant, while the
midbrain (short arrows) and anterior somites (long arrows) show a comparable level of expression. (E) and (F) are transverse sections of (C) and (D),
respectively, at the level of the primitive streak (arrowheads), where epiblast cells delaminate at the midline and migrate laterally to form mesoderm.
(G–J) Mouse embryos at 8.25 dpc with wild type (G,I) or N-cadherin 2/2 (H,J) genotypes, stained with Tbx6, a Wnt signal target gene, by RNA in situ
hybridisation. (G) and (H) are close-ups of the open neural plate region in the posterior. N-cadherin mutant embryos show a weaker Tbx6 expression.
Transverse sections at the level indicated by arrowheads are shown in I and J. The expression level of Tbx6 in delaminated mesodermal cells in the N-
cadherin 2/2 embryo is significantly low compared to that of wild type. Scale bars, 100 mm.
doi:10.1371/journal.pone.0023899.g006
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Drosophila and cell culture models [11,13,14,69,70]. Loss of E-
cadherin has been reported to induce colocalisation of b-catenin
with LEF1 in the nucleus [13], whilst it has been suggested that the
downregulation of E-cadherin during gastrulation results in a
release of membrane-bound b-catenin, allowing for its nuclear
translocation and an increase in Wnt signalling [71]. This has led to
the hypothesis that the level of cadherin expression in a cell sets a
threshold over which b-catenin must accumulate in order to
translocate into the nucleus and drive transcription. However, as
aforementioned, we find that there is no correlation between
cytoplasmic accumulation of b-catenin and transcriptional readout.
Importantly, however, it has been shown more recently that
whilst knockdown of E-cadherin augments b-catenin-dependent
transcription in colon cancer cells in which the Wnt pathway is
active, it has no effect in nontransformed keratinocytes that do not
display Wnt signalling [72]. Similarly, cancer cell lines that lack E-
cadherin do not exhibit a corresponding upregulation of b-catenin
signalling [73,74]. Moreover, depletion of E-cadherin in a mouse
model for pancreatic cancer (the Rip1Tag2 transgenic mouse) was
found not to contribute to Wnt/b-catenin signalling [75]. These
data indicate that the mere loss of E-cadherin is not sufficient to
activate b-catenin signalling. Although, in cells in which the
degradation machinery is compromised, or in cells already actively
engaged in Wnt signalling, loss of cadherin might act to amplify
the response to Wnt signals. For example, introduction of b-
catenin containing the Y654E mutation increases TCF-mediated
transcription [34,76]. This is opposite to our result that the Y654E
mutant is less competent to activate transcription (Fig. 5).
However, it is important to note that the aforementioned studies
used either mouse embryonic fibroblasts [76] or SW-480 cells
[34], which contain very little E-cadherin or/and have a
compromised b-catenin degradation pathway due to truncation
of APC [77,78].
Our data confirm that cadherin loss does not activate b-catenin
signalling, and suggest that the endocytosis of – rather than the
transcriptional downregulation of – cadherins can promote Wnt
signalling. We would argue that earlier suggestions that cadherin
levels set a threshold for Wnt/b-catenin signalling are only partly
correct. In MDCK cells, we propose that the high levels of E-
cadherin on the cell membrane keep the Wnt pathway off, and that
application of Wnt3a ligand or transfection of b-catenin has no
significant effect on pathway readout due to the strength of the E-
cadherin/b-catenin interaction. Pretreatment with HGF greatly
increases readout by both Wnt and b-catenin. This is not due to the
downregulation of E-cadherin, but probably due to increased
endocytosis and turnover of E-cadherin by HGF, which lead to
increased b-catenin being released into the cytoplasm. In fact, E-
cadherin levels in the membrane fraction increase with HGF
treatment (Figs 2G, 4F). This increase might be a byproduct of
increased turnover and trafficking to the membrane and may
account for HGF’s ability to potentiate the Wnt response.
Furthermore, although very high levels of cadherin might inhibit
Wnt pathway activity, too little also does; knockdown or loss of
cadherin results in a significantly reduced activation by b-catenin
and Wnt in both in vitro and in vivo contexts (Figs 5, 6). Moreover, b-
catenin that has reduced affinity for E-cadherin (Y654E) is far less
able to function in transcription (Fig. 4). So it seems that binding of b-
catenin to E-cadherin is required for its proper function, but that too
much E-cadherin can negatively affect the pathway by sequestration.
The positive role of cadherins in Wnt/b-catenin signalling
How might cadherin function to positively regulate the Wnt
pathway? It is obvious to think that cadherins could promote Wnt
signalling by stabilising b-catenin (albeit at the membrane) by
outcompeting b-catenin’s alternative binding partner, the Axin/
APC degradation complex [75,79]. Thus with cadherin loss, more b-
catenin becomes available for consumption by the degradation
complex. This supports the idea that cadherin loss could not increase
b-catenin stabilisation unless the degradation machinery was
somehow compromised [72]. However, we find that b-catenin
stabilisation and/or accumulation in the cytoplasm does not always
correlate with transcriptional activation. We postulate that cadherins
play a more instructive role in Wnt signalling; that binding to and
subsequently dissociating from cadherin somehow ‘primes’ b-catenin
for utilisation in signalling. We do not know what this priming event
involves, but, given the reduced transcriptional activation by Y654E,
do not believe it to be phosphorylation at this tyrosine residue. It has
previously been shown that Wnt signalling causes b-catenin to
preferentially bind TCF over cadherin [2]. It is interesting to propose
that binding to cadherin might generate a molecular form of b-
catenin that, once dissociated, is more active in signalling and that
the effect on signalling that differential binding affinities has is
different in different cell types, depending on the biological needs of
the cells/tissues and the identity of the ligands to which they are
responding. For example, in the absence of Wnt ligands but presence
of signals capable of inducing EMT, transcriptional activation by b-
catenin can still occur through utilisation of ‘primed’ b-catenin from
the membrane. In the presence of Wnt ligands, however, b-catenin
binds TCF over cadherin [2], thereby bypassing the need for this
priming event. Perhaps this goes some way in explaining why N-
cadherin knockdown in HEK293 cells reduces readout by b-catenin,
but not byWnt3a ligand (Fig. 6B); treatment withWnt3a generates a
TCF-selective b-catenin that is not affected by N-cadherin
knockdown, but in order for b-catenin, introduced directly into the
cell by transfection, to be utilised for signalling, it must first bind to
and be primed by N-cadherin.
It has been shown that newly synthesised b-catenin is bound to
E-cadherin in the ER and that this coupling facilitates efficient exit
of the complex from the ER and its subsequent trafficking to the
basolateral membrane [80,81]. One possible difference between
overexpressed b-catenin and endogenous b-catenin is a lack of this
interaction, due to shortage of the corresponding amount of
endogenous E-cadherin. Overexpressed b-catenin may be released
from the ER/Golgi into the cytoplasm without this coupling
process, and then accumulate in the cytoplasm, as seen in Fig. 3K.
It appears that cells with cadherin expression, active cadherin
turnover and intact endocytosis processes, together with a
mesenchymal morphology, are able to utilise overexpressed b-
catenin for signalling. It is not clear why MDCK cells treated with
HGF treatment are able to retain exogenous b-catenin in the
cytoplasm while untreated cells that maintain an epithelial
morphology are not (Fig. 3J,K). Perhaps differential b-catenin
retention is an intrinsic property of cells influenced by the events at
EMT and/or cell morphology.
Interplay between cell shape changes and pathway
activation
There are a number of examples where cell shape affects
pathway activation and, in turn, gene regulation. For example,
mesenchymal stem cells differentiate into either adipocytes or
osteoblasts in vitro, with the lineage decision depending on the
surface area of the substrate on which the cells are allowed to grow
[82]. In Drosophila embryos, mechanical deformation during
morphogenetic movement induces specific gene expression [83].
It is worth noting that both cases involve regulation of Wnt/
b-catenin signalling [83,84,85]. Perhaps sharing b-catenin between
the adhesion system and signalling is a method cells have adopted in
order to reflect morphological changes in gene regulation.
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Materials and Methods
Cell culture
HEK293T (ATCC) and MDCK cells [40] were maintained in
DMEM with 10% FCS and penicillin/streptomycin. E-cadherin
shRNA MDCK cells [40] were maintained additionally with
800 mg/ml G418 and 5 mg/ml blasticidin and the expression of
shRNAwas induced by adding 2 mg/ml tetracycline 48 hours before
use. Wnt3a conditioned medium was collected from L cells stably
expressing Wnt3a [86] and diluted 1:1 with the growing medium.
Human recombinant HGF (R&D) was used at 250 ng/ml and
cycloheximide at 20 mg/ml. HGF was applied in the last 16 hours
before collection unless stated otherwise. When using cycloheximide
and Wnt3a, cells were first treated with cycloheximide alone for
30 minutes, followed by a treatment with a mix of fresh
cycloheximide and Wnt3a for 4 hours. Similarly, cells were treated
with 50–400 mM Dynasore (Sigma) one hour before adding HGF.
Transfection and reporter assays
TOPflash reporter (Upstate) and Renilla luciferase (Promega),
together with control or b-catenin DNA where necessary, were
transfected using Polyfect (Qiagen) following the manufacturer’s
protocol. Cells were lysed 2 days after transfection and processed
for the Dual Luciferase Assay System (Promega). All data were
triplicate and analysed using student’s t-test. For N-cadherin
siRNA, lipofectamine 2000 (Invitrogen) was used following the
manufacturer’s protocol. Control and N-cadherin siRNA were
obtained from Santa Cruz (sc-44232, sc-29403, respectively).
Protein analyses
To collect cytosolic and membrane fractions, cells were grown
in 35 mm dishes and were collected with 100 ml cold hypotonic
buffer (10 mM TrisHCl pH 7.5, 0.2 mM MgCl2, with proteinase
inhibitor cocktail (Roche) and 1 mM AEBSF) with a cell scraper.
The extract was dounce homogenised and spun at 15,000 g for
45 minutes at 4uC, and the supernatant was collected as the
cytosolic fraction. The pellet was resuspended in 100 ml lysis buffer
(150 mM NaCl, 20 mM TrisHCl pH 7.5, 1% Triton X-100,
proteinase inhibitor cocktail (Roche) and 1 mM AEBSF). After
keeping on ice for 10 minutes, it was spun at 10,000 g for
10 minutes at 4uC, and the supernatant were collected as the
membrane fraction. Both fractions were incubated with Laemmli
sample buffer containing 5% b-mercaptoethanol at 100uC for
5 minutes before loading onto the gel. Antibodies used for
Westerns are; anti-b-catenin (Sigma), anti-active-b-catenin (anti-
ABC, clone 8E7, Millipore), anti-E-cadherin (BD Bioscience), anti-
b-tubulin (Sigma), anti-transferrin receptor (Santa Cruz), anti-flag
(Sigma) and anti-myc (Sigma). A431 cell lysate as a positive control
for anti-active-b-catenin antibody was provided by Millipore.
Immunocytochemistry
Cells grown on coverslips were fixed with 3% paraformaldehyde
in PBS for 30 minutes at 4uC, followed by incubation in 50 mM
NH4Cl and 0.2% Saponin in PBS for 15 minutes at room
temperature. After washing with PBS containing 0.2% gelatin and
0.02% Saponin, cells were incubated with primary and then
secondary antibodies. Antibodies used are; anti-b-catenin (Ab-
cam), anti-E-cadherin (BD Biosciences), anti-transferrin receptor
(Invitrogen), anti-Flag (Santa Cruz).
Q-PCR analyses
MDCK cells were transfected with TOPflash reporter DNA.
On the next day, cells were split into small dishes and treated with
HGF and/or cycloheximide for 6 hours. RNA was collected using
Trizol (Invitrogen) following manufacturer’s protocol. Additional
DNase treatment was performed to eliminate any contamination
of DNA. After cDNA synthesis, PCR reaction was performed
using Express SYBR GreenER (Invitrogen) on ABI 7500 (Applied
Biosystems). Data of triplicate average Ct were normalised with
that of GAPDH and then further converted to fold difference
relative to no-HGF, following manufacture’s protocol (Applied
Biosystems). P-values were calculated using DCT against GAPDH
using student’s t-test.
Mouse mutant analyses
N-cadherin flox mice with LoxP sites at the regions flanking the
exon 1 of N-cadherin [52] were mated with mice carrying the Cre
transgene expressed under a b-actin promoter [87]. Genotyping
was performed as described [52]. Individual embryos were fixed
with 4% paraformaldehyde in PBS and processed for in situ
hybridisation with LacZ or Tbx6 probes.
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